Related Experiment Videos

[New methods of stroke prevention in patients with chronic brain ischemia stages II-III, accompanied by

R S Megdiatov, V V Arkhipov

    Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
    |September 28, 2005
    PubMed

    Insights

    This study investigated optimizing cholesterol levels in patients with cerebrovascular diseases (CBI) using Liprimar and a novel free radical neutralizer. The combined treatment effectively reduced cholesterol, aiding in disease prevention.

    Area of Science:

    • Neurology
    • Cardiovascular Medicine
    • Biomedical Engineering

    Background:

    • Cerebrovascular diseases (CBI) are a major cause of disability and mortality globally.
    • Hypercholesterolemia is a significant, modifiable risk factor for developing cerebrovascular diseases.
    • Effective prevention strategies for CBI are crucial for public health.

    Purpose of the Study:

    • To evaluate the efficacy of Liprimar combined with a novel free radical neutralizer device for optimizing cholesterol levels.
    • To assess the impact of this combined therapeutic approach on patients with cerebrovascular diseases (CBI) of II-III stages.

    Main Methods:

    • A study involving 109 patients diagnosed with cerebrovascular diseases (CBI), stages II-III.
    • Treatment regimen included the drug Liprimar for cholesterol management.
    • A new physiotherapeutic device, a free radical neutralizer, was used concurrently.

    Main Results:

    • The combined therapy demonstrated success in optimizing cholesterol levels in the studied patient cohort.
    • Preliminary data suggests potential benefits for cerebrovascular disease management through cholesterol optimization.

    Conclusions:

    • Liprimar combined with a free radical neutralizer offers a promising approach for managing hypercholesterolemia in CBI patients.
    • Further research is warranted to fully elucidate the long-term benefits and mechanisms of this combined treatment strategy.

    Related Concept Videos

    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Atherosclerosis IV: Nursing Management01:23

    Atherosclerosis IV: Nursing Management

    Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
    Ischemic Stroke l: Introduction01:15

    Ischemic Stroke l: Introduction

    Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...